Reliably Assessing Duration of Protection for Coronavirus Disease 2019 Vaccines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35445269.
- Also identified by DOI 10.1093/infdis/jiac139 and PMC identifier 9383791.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Decision making about vaccination and boosting schedules for coronavirus disease 2019 (COVID-19) hinges on reliable methods for evaluating the longevity of vaccine protection. We show that modeling of protection as a piecewise linear function of time since vaccination for the log hazard ratio of the vaccine effect provides more reliable estimates of vaccine effectiveness at the end of an observation period and also detects plateaus in protective effectiveness more reliably than the standard method of estimating a constant vaccine effect over each time period. This approach will be useful for analyzing data pertaining to COVID-19 vaccines and other vaccines for which rapid and reliable understanding of vaccine effectiveness over time is desired.
Medical subject headings
- COVID-19
- Vaccines